Parameters predicting [18F]PSMA-1007 scan positivity and type and number of detected lesions in patients with biochemical recurrence of prostate cancer
Abstract Background Detection of the site of recurrence using PSMA-PET/CT is important to guide treatment in patients with biochemical recurrence of prostate cancer (PCa). The aim of this study was to evaluate the positivity rate of [18F]PSMA-1007-PET/CT in patients with biochemically recurrent PCa...
Main Authors: | Niloefar Ahmadi Bidakhvidi, Annouschka Laenen, Sander Jentjens, Christophe M. Deroose, Koen Van Laere, Liesbeth De Wever, Cindy Mai, Charlien Berghen, Gert De Meerleer, Karin Haustermans, Steven Joniau, Wouter Everaerts, Karolien Goffin |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2021-04-01
|
Series: | EJNMMI Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13550-021-00783-w |
Similar Items
-
Diagnostic Role of <sup>18</sup>F-PSMA-1007 PET/CT in Prostate Cancer Staging: A Systematic Review
by: Salam Awenat, et al.
Published: (2021-03-01) -
Automated [18F]PSMA-1007 production by a single use cassette-type synthesizer for clinical examination
by: Sadahiro Naka, et al.
Published: (2020-07-01) -
The value of 18F-PSMA-1007 PET/CT in identifying non-metastatic high-risk prostate cancer
by: Jun-jie Hong, et al.
Published: (2020-11-01) -
Procedures for the GMP-Compliant Production and Quality Control of [18F]PSMA-1007: A Next Generation Radiofluorinated Tracer for the Detection of Prostate Cancer
by: Jens Cardinale, et al.
Published: (2017-09-01) -
Optimization of [18F]PSMA-1007 PET-CT using regularized reconstruction in patients with prostate cancer
by: Elin Trägårdh, et al.
Published: (2020-05-01)